| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |